Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a report released on Saturday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Price Performance Shares of EGRX stock opened at $4.60 on Friday. The company’s 50-day simple moving average is $4.91 and its two-hundred day […]
More Stories
A Man on the Inside: Release Date, Trailer, Plot, and Episode Updates
Is your favourite detective, Ted Danson, returning with a season 3 of A Man on the Inside? Fans are looking...
8 Killed After Charter Plane Crashes in Western Alaska: US Military
By AldgraFredly The U.S. military said on Aug. 20 that eight people were killed after a charter plane crashed at...
Israel, Turkey Continue Dispute Over Syria After Airbase Strike
By Evgenia Filimianova Israel and Turkey have deepened their dispute over Syria after Israel defended its strike on a Syrian...
First Lady Unveils Racing Collaboration, $2 Million in ‘Fostering the Future’ Scholarships
By Travis Gillmore WASHINGTON—First Lady Melania Trump held her first public event in about two months at the White House...
US Unemployment Claims Unexpectedly Dropped Last Week
By Andrew Moran The number of Americans submitting applications for unemployment benefits unexpectedly declined last week for the first time...
A Tale of 2 Straits: Global Shippers Prefer Washington’s Version Over Tehran’s
By John Haughey With the Aug. 17 expiration of the 60-day memorandum of understanding between the United States and Iran,...